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Background: Data on hepatitis B (HB) infection prevalence among children and adolescents in 
Germany are scarce. We estimated seroprevalence of HB infection and assessed determinants for HB 
infection among children and adolescents in Germany from a representative population sample. 
 
Methods: From 2003 to 2006, the Robert Koch Institute conducted a nationwide cross-sectional 
Health Interview and Examination Survey for Children and Adolescents in Germany. Data on age, 
gender, migration background, and socioeconomic status were collected through questionnaires. A 
child was defined as having a 2-sided migration background if both parents, or the child and 1 parent, 
immigrated, and a 1-sided migration background if only 1 parent immigrated. Among children with 
migration background, a first-generation migrant was defined as born outside Germany; a second-
generation migrant was born in Germany. Information on HB vaccination status was obtained from 
vaccination cards. Serologic samples from participants were tested for anti-hepatitis B core antigen 
(anti-HBc) and hepatitis B surface antigen. We performed weighted univariable and multivariable 
logistic regression analyses to assess determinants for HB infection. 
Results: Of 13,065 participants (3–17 years), 0.5% (95% confidence interval [CI], 0.4–0.7) were anti-
HBc positive, among whom 38.7% (95% CI, 20.0 –57.5) were hepatitis B surface antigen positive. 
Two-sided migration background and being a first- or second-generation migrant were significantly 
associated with anti-HBc positivity (odds ratio [OR]: 8.3, 95% CI: 4.0 –17.4; OR: 11.0, 95% CI: 3.5–
35.0; OR: 3.0, 95% CI: 1.2–7.3). No further determinants were found. 
Conclusions: HB infection is rare among children and adolescents in Germany. First- and second-
generation migrant children can be considered to be at risk for HB infection, 2-sided migration 
background or being a first-generation migrant carried the greatest risk. Targeted testing for HB 
infection and early HB vaccination should be provided to immigrants’ children. 
 
 
Hepatitis B virus (HBV) infections acquired during childhood often run an asymptomatic course, but 
likely result in chronic infections that can progress to cirrhosis or hepatocellular carcinoma.1– 4 
 
Since 1995, the German Standing Vaccination Committee (STIKO) recommends HB vaccination for all 
infants from the age of 2 months, children and adolescents in Germany. Pre- and postvaccination 
serologic testing is not recommended for infants, children, and adolescents who are not at particular 
risk for HBV infection.5,6 Since 1994, hepatitis B surface antigen (HBsAg, a marker for a current HBV 
  
infection) screening of pregnant women is mandatory in Germany. Newborns of HBsAg-positive 
mothers receive a first dose of HB vaccine and passive immunization with HB immunoglobulin 
immediately after birth.5–8  
 
Even though there is knowledge on HB epidemiology among adults in Germany,9,10 to date, neither 
representative data on HB prevalence nor on risk factors for HBV infection among children and 
adolescents in Germany are available. The prevalence of antibodies to hepatitis B core antigen (anti-
HBc, a marker for a previous or current HBV infection) was 7.0% (95% confidence interval [CI], 6.4 –
7.6) and of HBsAg was 0.6% (95% CI: 0.4–0.8) among the adult population in Germany.9 According to 
the World Health Organization, Germany is categorized as a country with low HB endemicity 
(prevalence of HBsAg <2%).11 However,about 84% of adult immigrants residing in Germany migrated 
from countries with moderate to high HB endemicity (prevalence of HBsAg ≥2%). It has been 
estimated that 42% of all chronic HBV infections in Germany occur among immigrants, even though 
immigrants represent only 12.7% of the adult population in Germany.12 Therefore, it is hypothesized 
that offspring of immigrants may be at risk for HBV infection through perinatal transmission or person-
to-person contact within the household, reflecting HBV transmission modes shown to exist for 
children.13,14 In some other countries, migration background has been already identified to be a risk 
factor for HBV infection among children.15–19  
 
German clinical guidelines recommend testing persons migrated from regions with high HBsAg 
prevalence.20 However, actually, immigrants in Germany are not routinely tested for HBV infection. 
Beyond the HB vaccination recommendation for infants, children, and adolescents, the STIKO defined 
several particular risk groups for HBV infection and recommends HB vaccination for them.5 So far, the 
STIKO has not considered immigrants to be a particular risk group for HBV infection. Therefore, in 
Germany, 
for immigrants, there is no specific recommendation other than the universal HB vaccination starting at 
2 months of age, and no preor postvaccination serologic testing is currently recommended for 
immigrants or their children.5  
 
The Robert Koch Institute conducted a large populationbased nationwide Health Interview and 
Examination Survey for Children and Adolescents (KiGGS) in Germany from 2003 to 2006.  
 
The objectives of our study were to estimate seroprevalence of markers indicative for HBV infection 
among children and adolescents in Germany and to assess determinants for HBV infection to improve 
recommendations to prevent HBV infection for children. 
 
 
Materials and Methods 
 
The German Health Interview and Examination for Children and Adolescents (KiGGS) 
We performed a secondary data analysis of the KiGGS database. Detailed descriptions of the KiGGS 
methodology have been published elsewhere.21–26 In brief, the KiGGS was a crosssectional study 
conducted from May 2003 to May 2006 aiming at a nationally representative sample of children and 
adolescents 0 to 17 years of age with main residence in Germany.  
 
Participants of the KiGGS were enrolled in 2 steps. First, primary sample units were drawn from all 
German communities. Second, addresses of families per birth cohort were selected randomly from 
local resident registries.21  
 
Data on gender, date of birth, migration background, educational and occupational status of parents, 
and household income were collected through self-completed questionnaires. A child was defined as 
having a 2-sided migration background if both parents, or the child and 1 parent, had immigrated into 
Germany. If only 1 parent had immigrated, the child was defined as having a 1-sided migration 
background.22,23 Among the children and adolescents with a 1- or 2-sided migration background, a 
first-generation migrant was defined as being born outside Germany; a secondgeneration migrant was 
born in Germany. Only children and adolescents aged between 11 and 17 years were asked about 
their respective country of birth. Based on the data from the World Health Organization and the 
Centers for Disease Control and Prevention, children born in countries where prevalence of HBsAg is 
2% or more were classified as being from countries with moderate or high HB endemicity (Fig., 
Supplemental Digital Content 1, http://links.lww.com/INF/A555 ).11,27 Information on educational and 
occupational status of parents and household income was aggregated into a social status index. 
  
Children were classified as being from families with high, medium, or low socioeconomic status 
according to this social status index.24 Information on HB vaccination status was obtained from self-
held vaccination cards. A child was categorized as having been completely vaccinated against HBV 
infection if he or she had received a 3-dose HB mono- or bivalent vaccine, or a 4-dose HB hexavalent 
vaccine with a pertussis component.25 Nonmigrants and secondgeneration migrants were classified as 
being born before or after the HBsAg screening program was launched in pregnant women in 1994. 
 




Serum samples of children and adolescents from 3 years of age were tested for anti-HBc, and if 
positive, HBsAg was tested. Tests for anti-HBc and HBsAg were qualitative, and both tests based on 
the electrochemiluminescence immunoassay (ECLIA, Roche Diagnostics, Switzerland). Anti-HBc was 
determined at an automatic ELECSYS 2010 Analyzer. Details of the laboratory methods have 




To ensure that estimates derived from the KiGGS were representative at national level, survey weights 
had been developed to be applied throughout statistical analyses. This included weighting for 
sampling design as well as weighting to adjust for deviations between the design-weighted net sample 
and German population statistics (as of December 31, 2004)28 based on crossclassifications by age, 
gender, residence in Western or Eastern Germany, and nationality (German vs. non-German). 
Weighting corrected for differences in age structure and for oversampling of individuals from Eastern 
Germany, which had been performed to ensure sufficient statistical power. Prevalences and odds 
ratios were calculated and presented with a 95% CI. We performed x2 tests for trend to assess linear 
trend in HB-prevalence across different age groups and performed univariable and stepwise forward 
multivariable logistic regression analyses to assess determinants of HBV infection. Only variables 
indicating statistically significant associations with HBV infection in the univariable analysis were kept 
in a multivariable logistic regression model. We measured the impact of possible multicollinearity 
among migration background and migrants’ generation and among age group and existence of HBsAg 
screening in pregnant women in a regression model by considering the variance inflation factor 
(VIF).29 If the value of VIF was above 2.5, we created different multivariable logistic regression models 
to avoid possible multicollinearity and to estimate the separate effects of the variables on HBV 
infection. Two-sided tests were applied, and an alpha error level of 5% was considered acceptable. 






A total of 17,641 children and adolescents (8656 girls and 8985 boys) participated in the KiGGS 
(response: 66.6%).24 Anti-HBc serology results were available for 13,065 (88.6%) children and 
adolescents aged between 3 and 17 years. An overview of information on gender, age group, 
migration status, socioeconomic status, HB vaccination status, and being born before or after the 




Overall, 0.5% (95% CI, 0.4–0.7) of the children and adolescents aged between 3 and 17 years were 
anti-HBc positive, among whom 38.7% (95% CI, 20.0 –57.5) were HBsAg positive. Among the anti-
HBc positive children and adolescents, 56.8% were girls, 77.0% were 11 to 17 years, and 1.1% 
showed a 1-sided and 73.7% a 2-sided migration background. Information on migrants’ generation 
was available for 55.1% of the anti-HBc positive children and adolescents, of whom, 29.9% were first 
and 28.8% second-generation migrants. Among the anti-HBc positive children and adolescents, 
48.0% were from families with low socioeconomic status. Information on HB vaccination status was 
present for 57.0% of the anti-HBc positive children and adolescents, of whom, 54.9% had been 
completely vaccinated against HBV infection. Among the anti-HBc positive children and adolescents 
born in Germany, 65.4% were born after the HBsAgscreening of pregnant women was introduced.  
 
  
Anti-HBc prevalence increased with age in both genders (P = 0.001 for boys, P = 0.009 for girls). In 
each age group, the prevalence was higher in girls than in boys, however, the differences observed 
were not statistically significant (Fig. 1). 
 
Univariable Analysis of Determinants of Anti-HBc Positivity 
In univariable logistic regression analysis, the age groups 11 to 13 and 14 to 17 years, 2-sided 
migration background, being a first- or second-generation migrant, low socioeconomic status, and 
having no vaccination card were associated with anti-HBc positivity. The anti-HBc prevalence was 15 
times higher in children or adolescents who were first-generation migrants, 13 times higher in those 
being with 2-sided migration background, and 3 times higher in second-generation migrants than the 
one in nonmigrants, respectively. Anti-HBc prevalence was significantly higher among children and 
adolescents from families with low socioeconomic status in comparison to those from families with 
high socioeconomic status. Anti-HBc prevalence was higher among children and adolescents having 
no vaccination card than those having information on HB vaccination status. No significant differences 
regarding anti-HBc prevalence were found according to existence of the HBsAg screening in pregnant 
women among those born in Germany (Table 2). 
 
 
Multivariable Analysis of Determinants of Anti-HBc Positivity 
As the VIF for migration background and migrants’ generation was 6.5, we separated the both 
variables and created 2 different multivariable logistic regression models. Age group, socioeconomic 
status, and HB vaccination were included in both models. The VIF for age group and existence of 
HBsAg screening in pregnant women was 3.9, but since existence of HBsAg screening for pregnant 
women was not associated with anti-HBc positivity in univariable analysis, we did not consider it in the 
multivariable analysis.  
 
In a multivariable logistic regression model involving migration background (1-sided, 2-sided, or none), 
the age group 14 to 17 years, having a 2-sided migration background as well as having no vaccination 
card were independently associated with anti-HBc positivity. In another model involving migrants’ 
generation (first, second, or none), first- as well as second-generation migrant remained to be 





The population-based KiGGS survey enabled us to estimate nationwide and representative anti-HBc 
seroprevalence among children and adolescents in Germany.  
 
According to the findings of our study, it can be assumed that approximately 48,000 to 85,000 children 
and adolescents aged between 3 and 17 years with previous or current HBV infection (presence of 
anti-HBc positivity) currently live in Germany. Of those, 20.0% to 57.5% are assumed to have a 
current, replicative HBV infection (presence of anti-HBc and HBsAg positivity), and thus, are capable 
of transmitting the infection. Compared with the anti-HBc prevalence in the adult German population,9 
the prevalence among children and adolescents was substantially lower.  
 
In our study, migrants’ generation and migration background were closely related to one another and 
appeared to be multicollinear variables. One logistic regression model may not be able to reliably 
assess the independent contribution of each variable, therefore we investigated their impact 
separately.  
 
The prevalence of anti-HBc among children and adolescents with a 2-sided migration background and 
among those who were first- or second-generation migrants, respectively, was higher than anti-HBc 
prevalence among nonmigrants. Of the anti-HBc positive children and adolescents, almost three-
quarters showed a migration background, even though only 2807 (24.9%) participants in our study 
displayed a migration background, which is close to the proportion among children and adolescents in 
Germany (28.6%).30  
 
There may be several reasons for the markedly higher HB prevalence among children and 
adolescents with a migration background compared with those without.  
 
  
A migrant’s health status normally reflects the disease profile of his or her country of origin at least in 
the first years after their immigration.31,32 As the majority of the first-generation migrants in our study 
who indicated their country of birth had been born in countries with moderate or high HB endemicity, 
they presumably had been at risk for HBV infection in their countries of origin through perinatal 
transmission, person-to-person contact in household, kindergarten or school, or nosocomial 
transmission. This assumption is supported by our finding that anti-HBc prevalence among first-
generation migrants was higher than among second generation migrants and nonmigrants.  
 
Immigrants in industrialized countries are more likely to belong to a lower income class and to 
generally display lower living standards.31,32 This may stand as a proxy for an increased risk of HBV 
infection for children of immigrant families: there may be lesser health care seeking behavior, and 
family members suffering from replicative HBV infection may not see a physician on time, and may not 
receive appropriate medical treatment to reduce viral load, resulting in a considerable probability that a 
child is in close contact with infected family members. If a family member suffers from replicative HBV 
infection, HB vaccination for an infant, according to the schedule recommended in Germany, may be 
too late in time, and be performed only after infection had occurred already. It is assumed that HBsAg 
screening of pregnant women is an effective public health measure, but does not protect infants born 
into families where another family member than the mother displays replicative HBV infection.  
 
There is evidence that households with HB-infected family members represent a considerable hazard 
in terms of HBV infections.13,14 Lower living standards with overcrowding, or cultural habits which entail 
closer physical contacts to infants and children in the family context may further increase infection risk. 
In our study, univariable analysis suggested that children and adolescents from families with low 
socioeconomic status were more likely anti-HBc positive; however, multivariate analysis suggested 
that these differences were probably due to confounding with migration background or migrants’ 
generation.  
 
The HB prevalence among children and adolescents who had a 2-sided migration background was 
higher than the ones with only 1-sided migration background, which might suggest a potentially higher 
degree of exposure to HB infected family members in the household when a 2-sided migration 
background was present. Furthermore, 2-sided migrant children were partly born outside Germany; 
they could have been at risk for HBV infection prior to immigration, as well. In our study, no 
association between antiHBc positivity and 1-sided migration background was found, however, low 
statistical power owing to the small sample size of children with a 1-sided migration background might 
also contribute to the lack of association.  
 
Our finding regarding increasing HB prevalence with age of children and adolescents is in line with 
results from other studies33,34; however, this finding was not significant in a multivariable analysis 
involving migrants’ generation, which likewise might reflect lower statistical power as not all children 
with a migration background could be defined as first- or second-generation migrants and the sample 
size of the multivariable logistic regression model involving migrants’ generation was smaller. In 
Germany, children and adolescents aged 14 to 17 years in 2003 to 2006 were born before universal 
HB vaccination recommendation was implemented in Germany (1995) or before the HBsAg screening 
program for pregnant women was introduced (1994), and the HB vaccination catch-up campaign for 
adolescents is less successful. Indeed, among children and adolescents, the HB vaccination coverage 
was reported lower in older age group (11–17 years) than in younger age group (3–10 years).25 The 
higher prevalence of anti-HBc in older age groups may also suggest a cumulative risk for acquiring 
HBV infection over time. However, interpretation of these results are limited as the proportion of first-
generation migrants was higher in older than in younger age groups23 and stratification by migration 
status revealed imprecise results owing to the small sample size.  
 
In our study, no difference among being completely vaccinated and being unvaccinated or 
incompletely vaccinated regarding anti-HBc positivity was found. The KiGGS reported that more 
children and adolescents with a 2-sided migration background compared with those without a 
migration background could not provide complete vaccination cards (17.3% vs. 4.6%).22 They were 
therefore not considered in the analysis of the vaccination status and might have introduced a 
selection bias as children and adolescents with a 2-sided migration background, especially the first-
generation migrant children, were possibly less likely to have received HB vaccination than 
nonmigrants due to lack of recommendations on universal HB vaccination in some countries,3 but they 
were more likely to be anti-HBc positive. This is in line with our finding regarding high anti-HBc 




In the KiGGS, information on HBV infection status in family members of infected children was not 
obtained. Therefore, based on our data, it was impossible to estimate the actual HBV transmission 
mode among anti-HBc positive children and adolescents.  
 
Reflecting the inherent limitations of a cross-sectional study, it was impossible to determine the time of 
onset of HBV infection, or to distinguish whether infections of those participants with HBsAg were 
acute or already chronic, or to identify potential breakthrough infections.  
 
In Germany, no representative data on adherence to the guidelines for HBsAg screening for pregnant 
women are available—a regional study reported that HBsAg screening had been performed in 79.0% 
of pregnant women.35 Based on the data of KiGGS, it was impossible to identify whether the HBsAg 
screening was actually performed in mothers of the children. Classification was performed only by 
considering the year of childbirth among those born in Germany, most probably leading to some 
degree of misclassification. 
 
 
Conclusions and Recommendations 
Generally, HBV infection is uncommon among children and adolescents in Germany, but still, the 
prevalence findings from this study translate into several thousand children and adolescents suffering 
from replicative HBV infection.  
 
Owing to the high probability that HBV infections in infants and children run a chronic course but go 
unnoticed, and likely impair the health status of the affected due to liver associated morbidity and 
mortality in the long run (liver cirrhosis, hepatocellular carcinoma), efforts need to be intensified in 
Germany to aim at preventing all cases of HBV infection in infants and children, particularly by taking 
into consideration the target group of infants and children with a migration background.  
 
We conclude that those potentially at risk early in life, prior to the routinely recommended first dose of 
HB vaccine need to be identified and vaccinated as timely as possible.  
 
On the basis of our analysis, first- and second-generation migrant children can be considered to be at 
risk for HBV infection, with 2-sided migration background or being a firstgeneration migrant the most 
risky categories. Therefore, adherence of existing preventive programs needs to be reinforced, eg, 
HBsAg screening for all pregnant women, and particularly efforts need to be intensified to provide this 
service to all mothers with a migration background. Every infant of an HBsAg-positive mother should 
receive HB vaccination plus HB immunoglobulin5,8 and be followed up by serologic testing (anti-HBs) 
to avoid vertical transmission.  
 
Additionally, we strongly recommend that local health departments, pediatricians, and general 
practitioners provide information on HBV infection prevention, consider targeted testing of immigrants 
from regions with moderate or high HB endemicity and their family members,20,36 and perform HB 
vaccination especially to those immigrants’ children in a timely and consistent manner to avoid 
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Tables and Figures 
 
Table 1. Gender, Age Group, Migration Status, Socioeconomic Status, HB Vaccination Status, and 




*Information on country of birth was available for 247 first-generation migrants, of whom, 225 (89.6%) 
were born in countries with moderate or high HB endemicity. HBsAg indicates hepatitis B surface 





Table 2. Prevalence of Anti-HBc, Univariable, and Multivariable Logistic Regression Analyses for the 
Association Among Socio-demographic Variables, Vaccination Status, and HBsAg Screening in 





*In the multivariable logistic regression model, age group, migration background, socioeconomic 
status, and HB vaccination are included. 
†In the multivariable logistic regression model, age group, migrants’ generation, socioeconomic status, 
and HB vaccination are included. Anti-HBc indicates antibodies to hepatitis B core antigen; HBsAg, 




Figure 1. Anti-HBc prevalence by age group and gender among children and adolescents, Germany, 
2003–2006. 
 
 
 
  
